LYNOZYFIC
Generic: linvoseltamab-gcpt
- NDC
- 61755-054
- RxCUI
- 2719483
- Route
- INTRAVENOUS
- ICD-10 indication
- C90.00
Affordability Check
How much will you actually pay for LYNOZYFIC?
In 30 seconds, see every legitimate way to afford LYNOZYFIC — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About LYNOZYFIC
What is this medication? Lynozyfic is not a recognized or FDA-approved prescription medication. A review of major pharmaceutical databases and clinical literature indicates that no drug exists under this specific name for the treatment of any medical condition. It is possible that the term is a misspelling of another medication, such as Linezolid, which is an antibiotic used for serious infections, or Lynparza, which is a targeted therapy used in cancer treatment, but Lynozyfic itself has no verified therapeutic use or safety profile.
Because this is not a documented medication, you should not attempt to use any product labeled with this name without first consulting a healthcare provider or pharmacist. Using an unverified substance can result in severe health risks, as its ingredients, proper dosage requirements, and potential drug interactions are entirely unknown. Always double-check your prescription labels and rely on professional medical advice to ensure you are receiving the appropriate and safe treatment for your specific health needs.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for linvoseltamab-gcpt.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup LYNOZYFIC →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for linvoseltamab-gcpt →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Blenrep
Treats same condition · belantamab mafodotin
Pomalyst
Treats same condition · pomalidomide
XTRENBO
Treats same condition · Denosumab-qbde
CARMUSTINE
Treats same condition · Carmustine
Pomalidomide
Treats same condition · Pomalidomide
Sarclisa
Treats same condition · isatuximab
NINLARO
Treats same condition · ixazomib
EVOMELA
Treats same condition · Melphalan
Mozobil
Treats same condition · PLERIXAFOR
Melphalan Hydrochloride
Treats same condition · Melphalan hydrochloride
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
LYNOZYFIC treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.